ACCEL Lite: ACC.21 Late Breaker: The ATLANTIS Trial

<p>The ATLANTIS trial will change the way antithrombotic treatments are chosen after successful transcatheter aortic valve implantation. In this interview, Roxana Mehran, MD, FACC; Jean-Philippe Collet, MD; and Zaid I. Almarzooq, MBBCh, discuss anti-xa oral anticoagulation after valve implantation for aortic stenosis. For 20+ insider interviews like these every month with CME/MOC credit, subscribe to ACCEL at <em>www.ACC.org/ACCEL</em>.</p>